-
IIVS, RIFM and Shiseido Partner to Transfer Non-animal Photosafety Tests
IIVS, RIFM and Shiseido Partner to Transfer Non-animal Photosafety Tests The Institute for In Vitro Sciences (IIVS) has entered into an agreement with Shiseido and the Research...
July 14, 2020 -
IIVS’ Outreach Program for Non-animal Test Methods Supported by Chinese Cosmetic Company
June 23, 2020, Gaithersburg, MD – US based non-profit Institute for In Vitro Sciences Inc. (IIVS) has received its first funding from a Chinese owned and operated beauty...
June 22, 2020 -
Webinar : Use of Non-animal Skin Sensitization Methods
A recorded webinar on the “Use of Non-animal Skin Sensitization Methods” by IIVS’s Hans Raabe and US EPA’s Gino Scarano and James Cox is now available...
June 03, 2020
News & Resources
Media Inquiries? Start Here
-
Services and Tools for COVID-19 Drug Development
IIVS provides robust test systems and assays to detect the adverse effects of diverse materials, including pharmaceuticals targeting COVID-19. The IIVS Respiratory Toxicology...
May 21, 2020 -
Respiratory Toxicology for Pharmaceutical Development
The Institute for In Vitro Sciences (IIVS) provides robust test systems and assays to detect the adverse effects of diverse materials, including pharmaceuticals targeting...
May 06, 2020 -
FDA Releases New Guidance Recommending Alternatives to LLNA
FDA releases new guidance recommending the performance of alternative test methodologies in lieu of the murine-based Local Lymph Node Assay (LLNA) to assess skin sensitization...
April 22, 2020